Drug Trial Radar · NCT02658344
Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis
Last checked: Nov 19, 2026Latest source record: Jun 5, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Jul 2015
Primary completion
Nov 2016
Study completion Dec 2016
Sponsor
- Lead sponsor
- R-BioIndustry
- Sponsor type
- Industry
- First posted
- Jan 18, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with Knee Osteoarthritis.
Conditions
- Degenerative Arthritis
- Knee Osteoarthritis
Interventions
JOINTSTEMBiological
Jointstem (Autologous Adipose Tissue derived MSCs 1x10\^8cells/3ml), 1 time injection
Saline solutionDrug
Saline solution (Sodium chloride 9mg/ml), 1 time injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- WOMAC scoreTime frame: 24 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
KyungHee University Gangdong Hospital
Seoul, South Korea
GangNam Severance Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.